Johnson Emilie K, Finlayson Courtney
Division of Urology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Transgend Health. 2016 Jan 1;1(1):41-44. doi: 10.1089/trgh.2015.0010. eCollection 2016.
Gender and sex diverse individuals-transgender individuals and those with disorders of sex development (DSD)-both face medical treatments that may impair biological fertility potential. Young DSD patients also often have abnormal gonadal development. Fertility preservation for these populations has historically been poorly understood and rarely addressed. Future fertility should be discussed with gender and sex diverse individuals, particularly given recent advances in fertility preservation technologies and evolving views of fertility potential. Key ethical issues include parental proxy decision-making and uncertainty regarding prepubertal fertility preservation technologies. Many opportunities exist for advancing fertility-related care and research for transgender and DSD patients.
性别和性取向多元的个体——跨性别者和性发育障碍（DSD）患者——都面临着可能损害生物生育潜力的医学治疗。年轻的DSD患者通常也存在性腺发育异常的情况。历史上，对于这些人群的生育力保存了解甚少，也很少有人提及。应该与性别和性取向多元的个体讨论未来的生育问题，特别是考虑到生育力保存技术的最新进展以及对生育潜力不断变化的看法。关键的伦理问题包括父母代理决策以及青春期前生育力保存技术的不确定性。对于跨性别者和DSD患者，在推进与生育相关的护理和研究方面存在许多机会。
